异位性夜间血球蛋白尿症的发病因子
Lucio Luzzatto1, Shinji Nakao2
1University of Florence, Genova, Italy.
Blood
|March 16, 2025
概括
阴性夜间血红蛋白尿 (PNH) 是源于干细胞中的PIGA基因突变. 克隆扩张是由T细胞介导的自身免疫攻击驱动的,有利于突变细胞,并解释PNH病原体.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 阴性夜间血红蛋白尿 (PNH) 是一种非恶性克隆性造血性疾病.
- PNH的发病包括一个突变干细胞,具有PIGA基因突变和克隆扩张.
- 驱动克隆扩张的机制尚未完全理解.
研究的目的:
- 阐明帕洛克斯性夜间血红蛋白尿 (PNH) 中克隆扩张的基础机制.
- 调查自身免疫性攻击在PNH病变发生中的作用.
- 探索PNH和无形成性贫血 (AA) 之间的关系.
主要方法:
- 审查现有证据支持T细胞介导的自身免疫攻击.
- 在正常个体中分析PIGA突变微克隆.
- 对PNH的合成骨髓移植结果的检查.
- 对小鼠模型进行针对性piga失活的研究.
- 在PNH和AA患者中评估T细胞活性.
主要成果:
- 在PNH干细胞中始终发现PIGA突变.
- 在大多数PNH病例中,克隆扩张不是由二次突变驱动的.
- 有证据表明,T细胞对非突变干细胞的自身免疫攻击促进了GPI阴性 (PIGA突变) 干细胞的扩张.
- PNH与无塑性贫血 (AA) 有着共同的致病基因联系.
结论:
- PNH病原发生遵循达尔文的模型,涉及体质突变和特定的选择性环境.
- 通过T细胞介导的自身免疫在PNH中PIGA突变干细胞的克隆扩张中发挥着关键作用.
- 了解PNH的发病因子,可以让我们对无形成性贫血有所了解.
相关概念视频
01:21Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
01:24Disorders of Hemostasis
674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674
01:05Introduction to Hemostasis
4.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.7K
02:20Blood Types
17.3K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
17.3K
01:22Formation of the Platelet Plug
3.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.5K
02:45Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K